Abstract

The most relevant comorbidities in patients with peripheral artery disease (PAD) are coronary artery disease (CAD) and diabetes mellitus (DM). However, data of long-term follow-up of patients with chronic total occlusion (CTO) are scarce. The aim of the study was to assess the impact of CAD and DM on long-term follow-up patients after superficial femoral artery (SFA) CTO retrograde recanalization. In this study, eighty-six patients with PAD with diagnosed CTO in the femoropopliteal region and at least one unsuccessful attempt of antegrade recanalization were enrolled in 2 clinical centers. Mean time of follow-up in all patients was 47.5 months (±40 months). Patients were divided into two groups depending on the presence of CAD (CAD group: n = 45 vs. non-CAD group: n = 41) and DM (DM group: n = 50 vs. non-DM group: n = 36). In long-term follow-up, major adverse peripheral events (MAPE) occurred in 66.6% of patients with CAD vs. 36.5% of patients without CAD and in 50% of patients with DM vs. 55% of non-DM subjects. There were no statistical differences in peripheral endpoints in both groups. However, there was a statistically significant difference in all-cause mortality: in the DM group, there were 6 deaths (12%) (P value = 0.038). To conclude, patients after retrograde recanalization, with coexisting CTO and DM, are at higher risk of death in long-term follow-up.

Highlights

  • Coexistence of peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular disease causes almost 2 million deaths in Europe each year [1]

  • The aim of the study was to assess the influence of CAD and diabetes mellitus (DM) on the long-term follow-up in patients after superficial femoral artery (SFA) Chronic total occlusion (CTO) retrograde recanalization

  • Patients were divided into two groups depending on the presence of CAD (CAD: n = 45 vs. nonCAD: n = 41) and DM (DM: n = 50 vs. non-DM: n = 36)

Read more

Summary

Introduction

Coexistence of peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular disease causes almost 2 million deaths in Europe each year [1]. There are an increasing number of patients with PAD, who have increased mortality rate and higher risk of cardiovascular events; PAD is still underdiagnosed [2]. The most relevant comorbidities in patients with PAD are CAD and diabetes mellitus (DM) [3]. Recent studies have shown the impact of glycemia control and severity of CAD on patency of peripheral arteries in patients with PAD and poorer outcomes in long-term follow-up [5]. Patients with CTO in the femoropopliteal region require complex treatment of PAD and Journal of Diabetes Research comorbidities [1]. Data of long-term follow-up of patients with CTO are scarce. The aim of the study was to assess the influence of CAD and DM on the long-term follow-up in patients after superficial femoral artery (SFA) CTO retrograde recanalization

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call